Search

Your search keyword '"Gaki, Eleni"' showing total 96 results

Search Constraints

Start Over You searched for: Author "Gaki, Eleni" Remove constraint Author: "Gaki, Eleni"
96 results on '"Gaki, Eleni"'

Search Results

2. Safety and efficacy of risdiplam in patients with type 1 spinal muscular atrophy (FIREFISH part 2): secondary analyses from an open-label trial

3. SARS-Cov-2 Infection in Severe Asthma Patients Treated With Biologics

5. Demographic Change and Regional Specialisation: The Case of Greek NUTS II Regions.

6. RAINBOWFISH: Primary Efficacy and Safety Data in Risdiplam-treated Infants with Presymptomatic Spinal Muscular Atrophy (SMA) (S37.006)

8. The continuous challenge of cough in adults: A narrative review based on Hellenic Thoracic Society guidelines.

9. Switching from omalizumab to mepolizumab in severe asthmatics: A post hoc analysis of the RELight study

10. COVID-19 vaccination, acceptance, safety, and side-effects in European patients with severe asthma

12. Follow-up of patients with severe eosinophilic asthma receiving benralizumab for one year (gReek rEAl Life regIStry of benralizuMab: REALISM Study)

13. The clinical experience of patients with severe asthma and previous treatment with omalizumab, choosing mepolizumab in Greece.

14. MANOEUVRE Study Design: A Study of GYM329 (RO7204239) in Patients with Facioscapulohumeral Muscular Dystrophy (FSHD) (S2.010)

15. Does ISO 9001 certification benefit micro-SMEs? Empirical evidence from the industry

18. Safety and efficacy of risdiplam in patients with type 1 spinal muscular atrophy (FIREFISH part 2): secondary analyses from an open-label trial

20. RELIght: A two‐year REal‐LIfe study of mepolizumab in patients with severe eosinophilic asTHma in Greece: Evaluating the multiple components of response

21. FIREFISH Parts 1 and 2: 24-month Safety and Efficacy of Risdiplam in Type 1 SMA (S39.005)

22. Safety and efficacy of risdiplam in patients with type 1 spinal muscular atrophy (FIREFISH part 2): secondary analyses from an open-label trial

26. Tourist satisfaction with island destinations: an investigation on visitors to the Ionian islands, Greece

27. SARS-Cov-2 infection in asthma patients treated with biologics

28. Increase of breast-feeding in the past decade in Greece, but still low uptake: cross-sectional studies in 2007 and 2017

29. Follow-up of patients with severe eosinophilic asthma receiving mepolizumab for one year in specialized asthma clinics in Greece

33. Follow-up of patients with severe eosinophilic asthma receiving mepolizumab for one year in specialized asthma clinics in Greece

35. Increase of breast-feeding in the past decade in Greece, but still low uptake: cross-sectional studies in 2007 and 2017

36. Mepolizumab in Severe Eosinophilic Asthma: A 2-Year Follow-Up in Specialized Asthma Clinics in Greece: An Interim Analysis

37. REGIONAL TOURISM RESILIENCE AND RECOVERY IN TIMES OF CRISES.

38. Commonly setting biological standards in rare diseases

39. Commonly setting biological standards in rare diseases

42. Local tourism policy makers and e-image of destinations.

43. The evaluation of tourism satisfaction in island destinations: The case of the Ionian Islands of Greece

44. Greek tourism sector and signs of resilience

45. Assessing resilience in tourism: The case of Greece

46. TOURIST SATISFACTION WITH ISLAND DESTINATIONS: AN INVESTIGATION ON VISITORS TO THE IONIAN ISLANDS, GREECE.

47. Measuring regional inequalities in Greek tourism development

48. ECONOMIC CRISIS AND REGIONAL DISPARITIES

49. Regional Development and Income Distribution The Case of Greece

50. Alternative Ways of Overcoming a Region's Spatial Discontinuity

Catalog

Books, media, physical & digital resources